Sage Journals: Discover world-class research

Abstract

The interaction potential of peroxisome proliferators of similar and dissimilar structure was examined in B6C3F₁ mice. Mice were fed diets containing varying concentrations of ciprofibrate (Cipro), clofibrate (Clof) or di(2-ethylhexyl)phthalate (DEHP), or combinations of Cipro and Clof or Cipro and DEHP for 4 d. Induction of peroxisomal beta-oxidation, measured by increased acyl-CoA oxidase activity, was used as the endpoint for analysis. An additive response occurred following joint exposure to the structurally related compounds Cipro and Clof, whereas a possible synergistic response occurred at low dose combinations of the structurally dissimilar Cipro and DEHP. These findings represent the first report assessing the in-vivo interaction potential of structurally similar and dissimilar peroxisome proliferators and provides insight into the dose-response nature of joint exposures to certain non-genotoxic carcinogens.

Get full access to this article

View all access options for this article.

References

' Reddy JK & Lalwani ND Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidemic drugs and industrial platicizers to humans. CRC Critical Reviews in Toxicology 1983; 12: 1-58.

Elcombe CR & Mitchell AM Peroxisome proliferation due to di(2-ethylhexyl)phthalate (DEHP): species differences and possible mechanisms. Environmental Health Perspectives 1986; 70: 211-19.

Stott, WT Chemically induced proliferation of peroxisomes: implications for risk assesment . Regulatory Toxicology and Pharmacology 1988 ; 8: 125-59.

Gray Tjb , Lake BG , Beamand JA , Foster JR & Gangolli SD Peroxisome proliferation in primary cultures of rat hepatocytes. Toxicology and Applied Pharmacology 1983; 67: 15-25.

Lalwani ND , Fahl WE & Reddy JK Detection of a nafenopin binding protein in rat liver cytosol associated with the induction of peroxisome proliferation by hypolipidemic compounds. Biochemical and Biophysical Research Communications 1983; 116: 388-93.

Bieri F. , Bentley P. , Waechter F. & Stäubli W. Use of primary cultures of adult rat hepatocytes to investigate mechanisms of action of nafenopin, a hepatocarcinogenic peroxisome proliferator. Carcinogenesis 1984; 5: 1033-9.

Milton MM , Elcombe CR , Kass Gen & Gibson GG Lack of evidence for a hepatic peroxisome proliferator receptor and an explanation for the binding of hypolipidemic drugs to liver homogenates. Biochemistry and Pharmacology 1988; 37: 793-8.

Feller DR , Singh Y. , Shirhatti VR et al. Characterization of ciprofibrate and clofibric acid as peroxisomal proliferators in primary cultures of rat hepatocytes. Hepatology 1987; 7: 508-16.

Kocarek TA & Feller DR Quantitative assessment of enzyme induction by peroxisome proliferators and application to determination of effects on triglyceride biosynthesis in primary cultures of rat hepatocytes. Biochemistry and Pharmacology 1989; 38: 4169-76.

10.

Lundgren B. , Meijer J & DePierra JW. Examination of the structural requirements for proliferation of peroxisomes and mitochondria in mouse liver by hypolipidemic agents, with special emphasis on structural analogues of 2-ethylhexanoic acid . European Journal of Biochemistry 1987; 163: 423-31.

11.

" Small GM , Burdett K. & Connock MJ A sensitive spectrophotometric assay for peroxisomal acyl-CoA oxidase. Biochemical Journal 1985; 227: 205-10.

12.

Lowry OH , Rosebrough NJ , Farr AL & Randall RJ Protein measurement with Folin phenol reagent. Biological Chemistry 1951: 193: 265-75.

13.

Kleinbaum DG , Kupper LL & Muller KE Applied Regression Analysis and Other Multivariable Methods. Boston: PWS-KENT Publishing Co., 1988.

14.

Calabrese EJ Multiple Chemical Interactions, Ch. 14, pp. 426-30. Chelsea, MI: Lewis Publishers, Inc., 1991.

Effects of Joint Exposures to Selected Peroxisome Proliferators on Hepatic Acyl-CoA Oxidase Activity in Male B6C3F1 Mice

Abstract

Get full access to this article

References